RESEARCH-USE BIOSIMILAR ANTIBODY

Lilotomab

Antibody-drug conjugate · IgG1

CD37IgG1RUO

Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity.

TARGETCD37
YAntibody-drug conjugate
CATALOGSC-BS-420
CATALOG NUMBERSC-BS-420
MOLECULAR WEIGHTApprox. 145.24 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity.

Lilotomab is a recombinant research-use antibody directed against CD37.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte